What is the treatment for chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chlamydia Infection

The first-line treatment for chlamydia is doxycycline 100mg orally twice daily for 7 days, with azithromycin 1g orally as a single dose being an acceptable alternative when adherence is a concern. 1

Treatment Regimens by Patient Population

Adults and Adolescents (≥8 years)

  • First-line: Doxycycline 100mg orally twice daily for 7 days 1
  • Alternative: Azithromycin 1g orally as a single dose 1

Children

  • <45kg: Erythromycin base or ethylsuccinate 50mg/kg/day orally divided into four doses for 14 days 1, 2
  • >45kg but <8 years: Azithromycin 1g orally as a single dose 1

Pregnant Women

  • Recommended: Azithromycin 1g orally as a single dose 1
    • Doxycycline is contraindicated in pregnancy 1
  • Alternative: Erythromycin 500mg orally four times daily for at least 7 days 2
    • If not tolerated, 500mg orally every 12 hours or 250mg orally four times daily for at least 14 days 2

Efficacy Considerations

While both treatments are effective, there are important differences to consider:

  • Doxycycline has demonstrated superior efficacy for rectal chlamydial infections, with studies showing 99.6% cure rates compared to 82.9% for azithromycin 3
  • Single-dose azithromycin offers the advantage of directly observed therapy and improved adherence 4
  • Clinical trials have shown comparable efficacy between azithromycin and doxycycline for uncomplicated genital chlamydial infections, with cure rates of 96% and 98% respectively 5

Patient Management Guidelines

  • Patients should abstain from sexual activity until:

    • 7 days after single-dose therapy, OR
    • Until completion of the 7-day doxycycline regimen, AND
    • Until all partners are treated 1
  • Partner notification and treatment:

    • All sexual partners from the past 60 days should be notified, examined, and treated regardless of test results 1
    • Partner treatment is critical to prevent reinfection 1
  • Follow-up testing:

    • Test of cure is recommended for:
      • Pregnant women
      • When alternative regimens are used
      • When there are concerns about adherence
      • Persistent symptoms
      • Suspected reinfection 1
    • Test of cure should be conducted ≥3 weeks after treatment completion 1
    • Rescreening is recommended 3-6 months after treatment due to high risk of reinfection 1

Important Clinical Considerations

  • Always test for other STIs, including HIV and syphilis 1
  • For patients with poor compliance history, directly observed single-dose therapy with azithromycin may be preferable 1
  • If chlamydia and gonorrhea co-infection is present, treat with ceftriaxone 500mg IM single dose PLUS the appropriate chlamydia treatment 1
  • Patient education should emphasize:
    • Completing the full course of medication even if symptoms resolve
    • Partner treatment importance
    • Safe sex practices including consistent condom use 1

Common Pitfalls to Avoid

  • Failing to treat partners, which leads to high reinfection rates
  • Not testing for other STIs when chlamydia is diagnosed
  • Inadequate follow-up, especially for high-risk patients
  • Using azithromycin for rectal chlamydia infections, where doxycycline has superior efficacy
  • Not considering pregnancy status before prescribing doxycycline

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.